The exoskeleton rehabilitation market size has grown rapidly in recent years. It will grow from $1.3 billion in 2025 to $1.53 billion in 2026 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to increase in stroke cases, spinal cord injuries, rehabilitation technology adoption, shortage of therapists, demand for intensive therapy.
The exoskeleton rehabilitation market size is expected to see rapid growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to home-based rehabilitation growth, AI-guided therapy systems, aging population increase, expansion of neurorehabilitation, remote therapy monitoring. Major trends in the forecast period include robotic assisted rehabilitation, personalized therapy motion control, wearable mobility support systems, high precision movement training, data driven recovery monitoring.
The increasing incidence of disabilities is expected to drive the growth of the exoskeleton rehabilitation market going forward. Disabilities refer to long-term physical, sensory, or cognitive impairments that limit an individual’s ability to carry out daily activities. The rising incidence of disabilities is largely driven by neurological disorders, as improved survival rates following strokes and injuries often result in lasting impairments. Exoskeleton rehabilitation assists individuals with disabilities by offering wearable robotic support, making it suitable for those with restricted mobility. It lessens physical strain by enabling guided movement and repetitive therapy, enhancing functional recovery and independence. For example, in July 2025, Eurostat, a Luxembourg-based statistical office of the European Union (EU), reported that in 2024, 23.9% of people aged 16 or older in the EU experienced a disability or activity limitation. Therefore, the rising incidence of disabilities is contributing to the expansion of the exoskeleton rehabilitation market.
Major companies in the exoskeleton rehabilitation market are focusing on developing advanced products, such as customizable-speed exoskeleton systems, to enhance mobility and therapy outcomes. Customizable-speed exoskeleton systems refer to rehabilitation exoskeletons that allow therapists or users to adjust walking or movement speeds to meet individual therapy requirements and patient abilities. For example, in April 2025, Lifeward Ltd., an Israel-based medical device company, introduced the ReWalk 7 Personal Exoskeleton, a customizable-speed exoskeleton system. It is a wearable robotic exoskeleton that provides powered hip and knee movement, allowing individuals with paraplegia to stand, walk, and climb stairs. It features improved stability elements and a more intuitive user interface for initiating movement, enabling smoother transitions between daily activities with greater confidence and reduced physical strain.
In June 2025, Bioness Medical Inc., a US-based rehabilitation technology company, acquired Harmonic Bionics Inc. for an undisclosed amount. This acquisition allows Bioness Medical to strengthen its rehabilitation robotics portfolio by integrating Harmonic Bionics’ upper-extremity exoskeleton technology and expertise. Harmonic Bionics Inc. is a US-based rehabilitation robotics company specializing in upper-extremity exoskeleton solutions.
Major companies operating in the exoskeleton rehabilitation market are Ottobock SE and Co KGaA, Fourier Intelligence, DIH Holding US Inc., Cyberdyne Inc., Wandercraft SAS, Myomo Inc., Ekso Bionics Holdings Inc., Tyromotion GmbH, Lifeward Inc., Able Human Motion SL, Bioservo Technologies AB, ExoAtlet Global SA, Bama Teknoloji, Focal Meditech BV, B Temia Inc., Bionik Laboratories Corp, Gogoa Mobility Robots SL, Rex Bionics Ltd., Wearable Robotics Srl, Bionic Yantra Private Limited.
North America was the largest region in the exoskeleton rehabilitation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exoskeleton rehabilitation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the exoskeleton rehabilitation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have raised costs of robotic actuators, sensors, and control systems used in exoskeletons, particularly affecting Asia-Pacific manufacturing exports to Europe and North America. This has increased equipment prices but also encouraged local assembly, modular design innovation, and development of cost-optimized rehabilitation robots.
The exoskeleton rehabilitation market research report is one of a series of new reports that provides exoskeleton rehabilitation market statistics, including exoskeleton rehabilitation industry global market size, regional shares, competitors with a exoskeleton rehabilitation market share, detailed exoskeleton rehabilitation market segments, market trends and opportunities, and any further data you may need to thrive in the exoskeleton rehabilitation industry. This exoskeleton rehabilitation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Exoskeleton rehabilitation is a therapeutic approach that utilizes wearable robotic devices to support or enhance a person’s limb movements during recovery from injuries or neurological conditions. These devices guide and assist natural movement patterns in a controlled manner, helping retrain muscles and nerves through repeated, precise motions. This method promotes improved mobility, faster functional recovery, and increased independence for individuals with conditions such as stroke or spinal cord injury.
The main product types of exoskeleton rehabilitation systems include lower limb exoskeletons, upper limb exoskeletons, and full-body exoskeletons. Lower limb exoskeletons are wearable robotic devices designed to support, enhance, or restore mobility in the hips, legs, and lower body during rehabilitation or everyday movement. These solutions are available in both mobile and stationary formats and utilize powered or passive technologies. They are used for conditions such as neurological disorders, orthopedic disorders, spinal cord injuries, stroke, and others, and serve various end users including hospitals and clinics, rehabilitation centers, home care settings, and additional care environments.
The exoskeleton rehabilitation market consists of revenues earned by entities by providing services such as robotic-assisted gait training, mobility restoration therapy, strength and balance training, patient assessment and monitoring, and maintenance and support of rehabilitation exoskeleton systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The exoskeleton rehabilitation market also includes sales of wearable robotic exoskeletons, powered gait-assist devices, sensor-integrated mobility systems, pediatric rehabilitation exoskeletons, hip-knee-ankle exoskeleton systems, and related control units and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The exoskeleton rehabilitation market size is expected to see rapid growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to home-based rehabilitation growth, AI-guided therapy systems, aging population increase, expansion of neurorehabilitation, remote therapy monitoring. Major trends in the forecast period include robotic assisted rehabilitation, personalized therapy motion control, wearable mobility support systems, high precision movement training, data driven recovery monitoring.
The increasing incidence of disabilities is expected to drive the growth of the exoskeleton rehabilitation market going forward. Disabilities refer to long-term physical, sensory, or cognitive impairments that limit an individual’s ability to carry out daily activities. The rising incidence of disabilities is largely driven by neurological disorders, as improved survival rates following strokes and injuries often result in lasting impairments. Exoskeleton rehabilitation assists individuals with disabilities by offering wearable robotic support, making it suitable for those with restricted mobility. It lessens physical strain by enabling guided movement and repetitive therapy, enhancing functional recovery and independence. For example, in July 2025, Eurostat, a Luxembourg-based statistical office of the European Union (EU), reported that in 2024, 23.9% of people aged 16 or older in the EU experienced a disability or activity limitation. Therefore, the rising incidence of disabilities is contributing to the expansion of the exoskeleton rehabilitation market.
Major companies in the exoskeleton rehabilitation market are focusing on developing advanced products, such as customizable-speed exoskeleton systems, to enhance mobility and therapy outcomes. Customizable-speed exoskeleton systems refer to rehabilitation exoskeletons that allow therapists or users to adjust walking or movement speeds to meet individual therapy requirements and patient abilities. For example, in April 2025, Lifeward Ltd., an Israel-based medical device company, introduced the ReWalk 7 Personal Exoskeleton, a customizable-speed exoskeleton system. It is a wearable robotic exoskeleton that provides powered hip and knee movement, allowing individuals with paraplegia to stand, walk, and climb stairs. It features improved stability elements and a more intuitive user interface for initiating movement, enabling smoother transitions between daily activities with greater confidence and reduced physical strain.
In June 2025, Bioness Medical Inc., a US-based rehabilitation technology company, acquired Harmonic Bionics Inc. for an undisclosed amount. This acquisition allows Bioness Medical to strengthen its rehabilitation robotics portfolio by integrating Harmonic Bionics’ upper-extremity exoskeleton technology and expertise. Harmonic Bionics Inc. is a US-based rehabilitation robotics company specializing in upper-extremity exoskeleton solutions.
Major companies operating in the exoskeleton rehabilitation market are Ottobock SE and Co KGaA, Fourier Intelligence, DIH Holding US Inc., Cyberdyne Inc., Wandercraft SAS, Myomo Inc., Ekso Bionics Holdings Inc., Tyromotion GmbH, Lifeward Inc., Able Human Motion SL, Bioservo Technologies AB, ExoAtlet Global SA, Bama Teknoloji, Focal Meditech BV, B Temia Inc., Bionik Laboratories Corp, Gogoa Mobility Robots SL, Rex Bionics Ltd., Wearable Robotics Srl, Bionic Yantra Private Limited.
North America was the largest region in the exoskeleton rehabilitation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exoskeleton rehabilitation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the exoskeleton rehabilitation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have raised costs of robotic actuators, sensors, and control systems used in exoskeletons, particularly affecting Asia-Pacific manufacturing exports to Europe and North America. This has increased equipment prices but also encouraged local assembly, modular design innovation, and development of cost-optimized rehabilitation robots.
The exoskeleton rehabilitation market research report is one of a series of new reports that provides exoskeleton rehabilitation market statistics, including exoskeleton rehabilitation industry global market size, regional shares, competitors with a exoskeleton rehabilitation market share, detailed exoskeleton rehabilitation market segments, market trends and opportunities, and any further data you may need to thrive in the exoskeleton rehabilitation industry. This exoskeleton rehabilitation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Exoskeleton rehabilitation is a therapeutic approach that utilizes wearable robotic devices to support or enhance a person’s limb movements during recovery from injuries or neurological conditions. These devices guide and assist natural movement patterns in a controlled manner, helping retrain muscles and nerves through repeated, precise motions. This method promotes improved mobility, faster functional recovery, and increased independence for individuals with conditions such as stroke or spinal cord injury.
The main product types of exoskeleton rehabilitation systems include lower limb exoskeletons, upper limb exoskeletons, and full-body exoskeletons. Lower limb exoskeletons are wearable robotic devices designed to support, enhance, or restore mobility in the hips, legs, and lower body during rehabilitation or everyday movement. These solutions are available in both mobile and stationary formats and utilize powered or passive technologies. They are used for conditions such as neurological disorders, orthopedic disorders, spinal cord injuries, stroke, and others, and serve various end users including hospitals and clinics, rehabilitation centers, home care settings, and additional care environments.
The exoskeleton rehabilitation market consists of revenues earned by entities by providing services such as robotic-assisted gait training, mobility restoration therapy, strength and balance training, patient assessment and monitoring, and maintenance and support of rehabilitation exoskeleton systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The exoskeleton rehabilitation market also includes sales of wearable robotic exoskeletons, powered gait-assist devices, sensor-integrated mobility systems, pediatric rehabilitation exoskeletons, hip-knee-ankle exoskeleton systems, and related control units and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Exoskeleton Rehabilitation Market Characteristics
3. Exoskeleton Rehabilitation Market Supply Chain Analysis
4. Global Exoskeleton Rehabilitation Market Trends and Strategies
5. Exoskeleton Rehabilitation Market Analysis of End Use Industries
7. Global Exoskeleton Rehabilitation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Exoskeleton Rehabilitation Total Addressable Market (TAM) Analysis for the Market
9. Exoskeleton Rehabilitation Market Segmentation
10. Exoskeleton Rehabilitation Market Regional and Country Analysis
11. Asia-Pacific Exoskeleton Rehabilitation Market
12. China Exoskeleton Rehabilitation Market
13. India Exoskeleton Rehabilitation Market
14. Japan Exoskeleton Rehabilitation Market
15. Australia Exoskeleton Rehabilitation Market
16. Indonesia Exoskeleton Rehabilitation Market
17. South Korea Exoskeleton Rehabilitation Market
18. Taiwan Exoskeleton Rehabilitation Market
19. South East Asia Exoskeleton Rehabilitation Market
20. Western Europe Exoskeleton Rehabilitation Market
21. UK Exoskeleton Rehabilitation Market
22. Germany Exoskeleton Rehabilitation Market
23. France Exoskeleton Rehabilitation Market
24. Italy Exoskeleton Rehabilitation Market
25. Spain Exoskeleton Rehabilitation Market
26. Eastern Europe Exoskeleton Rehabilitation Market
27. Russia Exoskeleton Rehabilitation Market
28. North America Exoskeleton Rehabilitation Market
29. USA Exoskeleton Rehabilitation Market
30. Canada Exoskeleton Rehabilitation Market
31. South America Exoskeleton Rehabilitation Market
32. Brazil Exoskeleton Rehabilitation Market
33. Middle East Exoskeleton Rehabilitation Market
34. Africa Exoskeleton Rehabilitation Market
36. Exoskeleton Rehabilitation Market Competitive Landscape and Company Profiles
37. Exoskeleton Rehabilitation Market Other Major and Innovative Companies
40. Exoskeleton Rehabilitation Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Exoskeleton Rehabilitation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses exoskeleton rehabilitation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for exoskeleton rehabilitation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exoskeleton rehabilitation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Lower Limb Exoskeletons; Upper Limb Exoskeletons; Full Body Exoskeletons2) By Mobility: Mobile; Stationary
3) By Application: Neurological Disorders; Orthopedic Disorders; Spinal Cord Injury; Stroke; Other Applications
4) By End-User: Hospitals And Clinics; Rehabilitation Centers; Other End-Users
Subsegments:
1) By Lower Limb Exoskeletons: Neurorehabilitation Systems; Gait Training Systems; Mobility Assistance Systems; Balance Support Systems2) By Upper Limb Exoskeletons: Arm Rehabilitation Systems; Hand Rehabilitation Systems; Shoulder Support Systems; Elbow Assistance Systems; Wrist Assistance Systems
3) By Full Body Exoskeletons: Integrated Rehabilitation Systems; Whole Body Support Systems; Multi Joint Assistance Systems; Full Mobility Assistance Systems; Postural Support Systems
Companies Mentioned: Ottobock SE and Co KGaA; Fourier Intelligence; DIH Holding US Inc.; Cyberdyne Inc.; Wandercraft SAS; Myomo Inc.; Ekso Bionics Holdings Inc.; Tyromotion GmbH; Lifeward Inc.; Able Human Motion SL; Bioservo Technologies AB; ExoAtlet Global SA; Bama Teknoloji; Focal Meditech BV; B Temia Inc.; Bionik Laboratories Corp; Gogoa Mobility Robots SL; Rex Bionics Ltd.; Wearable Robotics Srl; Bionic Yantra Private Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Exoskeleton Rehabilitation market report include:- Ottobock SE and Co KGaA
- Fourier Intelligence
- DIH Holding US Inc.
- Cyberdyne Inc.
- Wandercraft SAS
- Myomo Inc.
- Ekso Bionics Holdings Inc.
- Tyromotion GmbH
- Lifeward Inc.
- Able Human Motion SL
- Bioservo Technologies AB
- ExoAtlet Global SA
- Bama Teknoloji
- Focal Meditech BV
- B Temia Inc.
- Bionik Laboratories Corp
- Gogoa Mobility Robots SL
- Rex Bionics Ltd.
- Wearable Robotics Srl
- Bionic Yantra Private Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.53 Billion |
| Forecasted Market Value ( USD | $ 2.91 Billion |
| Compound Annual Growth Rate | 17.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
